Atlas Trials

Retrospective Evaluation of Nivolumab in Adjuvant Esophageal Cancer/Gastroesophageal Junction Cancer

Clinical trial NCT06499298 · COMPLETED

Trial details

NCT number
NCT06499298
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Study type
OBSERVATIONAL
Esophageal CancerGastroesophageal Junction Cancer
Start date
2024-12-03
Primary completion
2025-04-16
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.